Skip to main content
. 2019 Jun 3;43:460–472. doi: 10.1016/j.ebiom.2019.04.054

Table 2.

Quantitative imaging data as related to clinical outcome.

eGOS ≤ 5 eGOS>5 n of eGOS ≤ 5, n of eGOS>5 OR (95% CI) p-value AUC (95% CI) PC NPC n of PC, n of NC OR (95% CI) p-value AUC (95% CI)
Age, years 57·00 (48·00–65·00) 52·00 (44·00–59·00) 69, 43 1·06 (1·02–1·10) 0·0261 0·62 (0·51–0·73) 57·00 (48·00–65·00) 52·00 (44·00–60·00) 78, 46 1·04 (1·00–1·07) 0·0351 0·62 (0·51–0·73)
WFNS 4 (2–5) 2 (1–4·5) 69, 43 1·60 (1·22–2·11) 0·0007 0·66 (0·55–0·77) 4 (2–5) 2 (1–4·5) 78, 46 1·56 91·21–2·01) 0·0005 0·65 (0·55–0·75)
RMS 7 (5–8) 5 [[3], [4], [5], [6], [7]] 69, 43 1·73 (1·33–2·24) 0·0002 0·75 (0·65–0·85) 7 (5–8) 5 [[3], [4], [5], [6], [7]] 78, 46 1·52 (1·22–1·90) 0·0002 0·71 (0·62–0·81)



ABT volume, ml
ABT1 85·24 (58·95–131·88) 55·82 (34·79–98·11) 69, 43 1·01 (1·00–1·02) 0·0401 0·67 (0·58–0·79) 84·31 (54·69–131·57) 56·25 (35·19–102·02) 78, 46 1·01 (1·00–1·02) 0·0410 0·66 (0·57–0·79)
ABT2 111·46† (80·47–219·23) 68·05 (33·05–105·38) 42, 24 1·02 (1·01–1·04) 0·0040 0·74 (0·62–0·88) 109·88† (80·47–219·23) 67·46 (33·05–115·15) 47, 25 1·02 (1·01–1·03) 0·0045 0·74 (0·62–0·87
ABT3 134·98† (91·94–199·37) 59·75 (28·68–93·24) 62, 37 1·02 (1·01–1·04 0·0002 0·83 (0·74–0·92) 134·55† (91·42–205·27) 61·39 (30·71–102·64) 71, 40 1·02 (1·01–1·03) 0·0003 0·80 (0·71–0·89
ABT4 138·71† (102·79–204·39) 29·55† (15·78–73·55) 36, 33 1·03 (1·02–1·05) 0·0002 0·88 (0·81–0·97) 138·66† (99·23–204·39) 29·55† (16·92–71·70) 37, 33 1·03 (1·02–1·05) 0·0002 0·88 (0·80–0·96



NBT volume, ml
NBT1 1496·3 (1359·1–1568·5) 1461·8 (1370·5–1530·8) 69, 43 ·· 0·7218 ·· 1503·0 (1401·2–1575·0) 1455·6 (1364·4–1522·0) 78, 46 ·· 0· 4101 ··
NBT2 1425·2 (1349·7–1534·9) 1452·0 (1384·1–1515·1) 42, 24 ·· 0·4159 ·· 1425·7 (1350·1–1534·9) 1440·8 (1377·1–1515·1) 47, 25 ·· 0·5738 ··
NBT3 1383·3† (1276·6–1480·7) 1451·4 (1373·2–1531·6) 62, 37 ·· 0·0869 ·· 1390·0 † (1287·5–1495·1) 1442·5 (1366·6–1521·4) 71, 40 ·· 0·0908 ··
NBT4 1347·4† (1198·6–1411·8) 1475·5 (1410·8–1542·3) 36, 33 0·99 (0·98–1·00) 0·0025 0·81 (0·70–0·91) 1351·8† (1198·6–1437·0) 1469·3 (1389·9–1537·0) 37, 33 0·99 (0·99–1·00) 0·0055 0·77 (0·66–0·89)



LV volume, ml
LV1 36·59 (22·59–57·57) 35·13 (23·18–48·08) 69, 43 ·· 0·7216 ·· 33·81 (20·36–51·44) 35·18 (23·81–49·51) 78, 46 ·· 0·9792 ··
LV2 34·30 (18·44–50·59) 27·86 (21·31–37·19) 42, 24 ·· 0·8668 ·· 30·47 (17·92–49·00) 27·52 (21·31–37·19) 47, 25 ·· 0·9723 ··
LV3 40·04 (22·00–60·38) 35·87 (22·00–54·46) 62, 37 ·· 0·2754 ·· 38·29 (23·10–60·27) 36·32 (27·60–54·46) 71, 40 ·· 0·8910 ··
LV4 68·29† (47·98–108·98) 45·62 (32·07–69·85) 36, 33 1·02 (1·00–1·03) 0·0153 0·67 (0·54–0·80 71·51† (50·90–109·39) 44·69⁎‡ (30·77–56·16) 37, 33 1·03 (1·01–1·05) 0·0012 0·74 (0·62–0·86)



SAS volume, ml
SAS1 267·08 (154·80–379·21) 228·55 (150·32–344·57) 69, 43 ·· 0·2901 ·· 257·66 (148·10–354·18) 246·45 (160·75–377·70) 78, 46 ·· 0·8161 ··
SAS2 159·26† (107·35–296·91) 195·45 (147·68–298·13) 42, 24 ·· 0·3408 ·· 157·28† (104·13–296·91) 196·00 (147·69–319·27) 47, 25 ·· 0·2162 ··
SAS3 231·66 (154·20–337·51) 233·05 (145·36–349·60) 62, 37 ·· 0·6926 ·· 221·41 (148·19–333·90) 257·89 (187·68–401·95) 71, 40 ·· 0·5036 ··
SAS4 447·19† (272·10–564·83) 361·93 (281·57–481·77) 36, 33 ·· 0·1223 ·· 450·92† (272·10–564·83) 363·43 (281·57–497·71) 37, 33 ·· 0·1584 ··



ABTBBBD volume, ml
ABTBBBD1 19·23 (9·53–24·57) 11·72 (9·08–22·17) 49, 30 1·06 (1·01–1·11) 0·0109 0·68 (0·55–0·80) 23·02 (12·01–31·08) 12·13 (9·23–22·83) 59, 34 1·05 (1·01–1·09) 0·0177 0·66 (0·54–0·78)
ABTBBBD2 27·60† (14·83–48·23) 19·20 (8·68–25·24) 32, 18 1·05 (1·01–1·10) 0·0184 0·69 (0·52–0·86) 39·11† (19·06–60·50) 18·80 (7·82–24·73) 35, 20 1·06 (1·01–1·11) 0·0088 0·72 (0·56–0·88)
ABTBBBD3 35·88† (23·77–56·47) 14·55 (8·84–36·32) 50, 28 1·05 (1·02–1·08) 0·0004 0·79 (0·68–0·90) 44·14† (28·15–71·10) 15·54 (8·83–37·41) 58, 30 1·05 (1·02–1·08) 0·0002 0·78 (0·67–0·89)
ABTBBBD4 19·91 (13·12–43·18) 5·90† (2·89–13·87 23, 21 1·07 (1·02–1·13) 0·0071 0·85 (0·73–0·97) 24·38 (18·23–50·99) 5·84† (2·89–11·33) 24, 22 1·08 (1·02–1·14) 0·0077 0·85 (0·73–0·97)



NBTBBBD volume, ml
NBTBBBD1 127·05 (109·78–160·60) 106·70⁎‡ (62·94–128·60) 49, 30 1·02 (1·01–1·04) 0·0017 0·73 (0·61–0·82) 129·47 (111·38–161·72) 102·08⁎‡ (65·53–127·64) 59, 34 1·03 (1·01–1·04) 0·0003 0·73 (0·62–0·84)
NBTBBBD2 135·41a (90·94–180·24) 90·94 (64·84–115·12) 32, 18 1·03 (1·01–1·05) 0·0086 0·80 (0·64–0·94) 140·32 (104·34–191·58) 90·23 (62·70–102·74) 35, 20 1·04 (1·02–1·07) 0·0019 0·84 (0·71–0·97)
NBTBBBD3 127·72 (102·66–167·98) 94·63 (72·22–110·45) 50, 28 1·02 (1·01–1·04) 0·0016 0·77 (0·65–0·88) 127·72 (102·66–167·98) 94·63 (70·52–109·71) 58, 30 1·03 (1·01–1·05) 0·0002 0·77 (0·66–0·88)
NBTBBBD4 105·61† (79·18–146·66) 69·87 (54·99–97·62) 23, 21 1·03 (1·01–1·05) 0·0114 0·75 (0·61–0·90) 110·68† (79·21–147·64) 67·52 (54·99–92·29) 24, 22 1·04 (1·01–1·07) 0·0031 0·79 (0·65–0·93)



ABTBBBD10volume, ml
ABTBBBD110 42·19 (28·51–60·71) 29·19 (17·29–46·95) 49, 30 1·04 (1·01–1·06) 0·0092 0·66 (0·53–0·78) 45·78 (28·68–65·18) 29·63 (18·58–45·26) 59, 34 1·04 (1·01–1·06) 0·0077 0·67 (0·54–0·79)
ABTBBBD210 51·74 (38·48–72·96) 28·42 (15·92–47·61) 32, 18 1·05 (1·01–1·08) 0·0076 0·77 (0·62–0·93) 55·58 (40·57–74·87) 28·42 (13·77–43·44) 35, 20 1·09 (1·04–1·16) 0·0001 0·81 (0·67–0·95)
ABTBBBD310 52·14 (34·98–74·48) 28·11 (17·88–38·96) 50, 28 1·04 (1·01–1·06) 0·0022 0·76 (0·65–0·88) 52·14 (34·98–74·48) 28·11 (17·82–39·98) 58, 30 1·05 (1·02–1·07) 0·0004 0·76 (0·64–0·87)
ABTBBBD410 36·67† (24·35–54·67) 9·98† (6·65–23·52) 23, 21 1·08 (1·03–1·14) 0·0012 0·85 (0·73–0·97) 36·66† (24·74–54·31) 9·47† (6·65–20·89) 24, 22 1·09 (1·04–1·16) 0·0009 0·87 (0·76–0·98)



ABTBBBD20volume, ml
ABTBBBD120 38·89 (29·32–47·82) 27·50 (20·35–48·14) 49, 30 1·02 (0·99–1·05) 0·0824 0·61 (0·48–0·74) 39·16 (30·12–48·89) 30·41 (21·07–42·53) 59, 34 1·03 (1·00–1·06) 0·0264 0·64 (0·52–0·76)
ABTBBBD220 35·51 (30·21–50·70) 28·61 (16·60–34·74) 32, 18 1·06 (1·01–1·12) 0·0225 0·76 (0·53–0·87) 35·59 (27·83–50·98) 25·02 (15·84–34·51) 35, 20 1·09 (1·03–1·16) 0·0040 0·77 (0·60–0·91)
ABTBBBD320 33·71 (26·32–44·09) 25·64 (17·03–32·99) 50, 28 1·06 (1·02–1·11) 0·0049 0·74 (0·58–0·83) 33·71 (25·42–44·35) 25·64 (16·70–30·37) 58, 30 1·07 (1·03–1·12) 0·0013 0·74 (0·59–0·83)
ABTBBBD420 34·60 (29·37–50·75) 18·39 (7·76–30·01) 23, 21 1·08 (1·02–1·14) 0·0039 0·79 (0·65–0·92) 34·69 (29·73–50·28) 17·94† (7·76–28·12) 24, 22 1·10 (1·03–1·17) 0·0017 0·82 (0·67–0·95)

OR = odds ratio. PC = progressive course of aSAH. NPC = non-progressive course of aSAH.

Significant difference ≤ 0·05 between outcome groups (eGOS ≤ 4, vs eGOS>4, or PC vs NC) with Wilcoxon sum-rank test. Significant difference ≤ 0·05 between different time points with Friedman test†. Significant difference ≤ 0·05 between control and a measurement at a single time point with Wilcoxon sum-rank test‡. The area under the ROC curve (AUC) results were considered “excellent” for AUC values between 0·9–1, “good” for AUC values between 0·8–0·9, “fair” for AUC values between 0·7–0·8, “poor” for AUC values between 0·6–0·7 and failed for AUC values between 0·5–0·6.

Only significant OR values were presented in the table.